---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-21-215904"
form_type: "8-K"
ticker: "CLOV"
cik: "0001801170"
company_name: "CLOVER HEALTH INVESTMENTS, CORP. /DE"
filed_at: "2021-07-15T23:59:59+00:00"
generated_at: "2026-06-30T05:11:19.717065+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Clover Health CFO Joseph Wagner to step down Aug 13; Mark Herbers named interim CFO

## Summary
- CFO Joseph Wagner departs Aug 13, 2021 for personal reasons; no disagreement with company.
- Mark Herbers of AlixPartners appointed interim CFO effective Aug 13; permanent search underway.
- Lee Shapiro (Audit Committee Chair) leads search committee; executive search firm engaged.
- Wagner cites family health challenges; says decision not related to company operations or policies.

## SEC filing metadata
- accession: 0001193125-21-215904
- form_type: 8-K
- ticker: CLOV
- cik: 0001801170
- company_name: CLOVER HEALTH INVESTMENTS, CORP. /DE
- filed_at: 2021-07-15T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1801170/000119312521215904/0001193125-21-215904-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1801170/000119312521215904/d175914d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-21-215904
- JSON: https://secwatch.observer/filing/0001193125-21-215904.json
- Plain text: https://secwatch.observer/filing/0001193125-21-215904.txt

## Key facts
- Executive change
  Mark Herbers was appointed as Interim Chief Financial Officer at CLOVER HEALTH INVESTMENTS, CORP. /DE.
  - Action: appointed
  - Role: Interim Chief Financial Officer
  source text: Effective upon the Departure Date, and until a permanent replacement for Mr. Wagner has been named, Mark Herbers will serve as the Company’s interim Chief Financial Officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1801170/000119312521215904/0001193125-21-215904-index.htm
- Executive change
  Joseph Wagner departed as Chief Financial Officer at CLOVER HEALTH INVESTMENTS, CORP. /DE.
  - Action: stepping down
  - Role: Chief Financial Officer
  source text: On July 15, 2021, Clover Health Investments, Corp. (the “Company”) announced that Joseph Wagner, the Company’s Chief Financial Officer, will be stepping down as an officer of the Company on August 13, 2021 (the “Departure Date”), following the filing of the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2021 (the “Second Quarter 2021 Form 10-Q”), for personal reasons.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1801170/000119312521215904/0001193125-21-215904-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.